Vildagliptin added to basal insulin glargine improves glycaemic control and reduces glycaemic excursions in type 2 diabetes

被引：0
|
作者：
Brooks, J. [1 ]
Bravis, V. [1 ,2 ]
Morgenstern, S. [1 ]
Hui, E. [1 ]
Gohel, B. [1 ]
Savarananthan, T. [1 ]
Carrolls, M. [1 ]
Devendra, D. [1 ,2 ]
机构：
[1] Cent Middlesex Hosp, Jeffrey Kelson Diabet Ctr, London NW10 7NS, England
[2] Univ London Imperial Coll Sci Technol & Med, Dept Investigat Sci, London, England
来源：
DIABETOLOGIA | 2009年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
750
引用
收藏
页码：S294 / S295
页数：2
相关论文
共 50 条
  • [1] Addition of vildagliptin to insulin improves glycaemic control in type 2 diabetes
    Fonseca, V.
    Schweizer, A.
    Albrecht, D.
    Baron, M. A.
    Chang, I.
    Dejager, S.
    [J]. DIABETOLOGIA, 2007, 50 (06) : 1148 - 1155
  • [2] Addition of vildagliptin to insulin improves glycaemic control in type 2 diabetes
    V. Fonseca
    A. Schweizer
    D. Albrecht
    M. A. Baron
    I. Chang
    S. Dejager
    [J]. Diabetologia, 2007, 50 : 1148 - 1155
  • [3] Lixisenatide added to basal insulin reduces glycaemic variability in patients with type 2 diabetes mellitus
    O'Neal, D.
    Umpierrez, G.
    DiGenio, A.
    Goldenberg, R.
    Hernandez-Triana, E.
    Lin, J.
    Park, C. -Y.
    Renard, E.
    Kovatchev, B.
    [J]. DIABETOLOGIA, 2014, 57 : S342 - S342
  • [4] Improved glycaemic control with vildagliptin added to insulin, with or without metformin, in patients with type 2 diabetes mellitus
    Kothny, W.
    Foley, J.
    Kozlovski, P.
    Shao, Q.
    Gallwitz, B.
    Lukashevich, V.
    [J]. DIABETES OBESITY & METABOLISM, 2013, 15 (03): : 252 - 257
  • [5] Long-term glycaemic control with insulin glargine in Type 2 diabetes
    Kacerovsky-Bielesz, G
    Dressler, A
    Freunscht, R
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2006, 71 (02) : 184 - 191
  • [6] Switching to insulin glargine 300 U/ml in patients with type 2 diabetes on basal insulin supported oral therapy (BOT) improves glycaemic control
    Seufert, J.
    Fritsche, A.
    Anderten, H.
    Pegelow, K.
    Pscherer, S.
    Pfohl, M.
    [J]. DIABETOLOGIA, 2018, 61 : S441 - S441
  • [7] Effect of vildagliptin added to insulin on glycaemic control in haemodialysis patients with type 2 diabetes: a randomised multicentre prospective study
    Smagala, A.
    Munch, M.
    Meyer, L.
    Klein, A.
    Guercy, B.
    Frimat, L.
    Borot, S.
    Ducloux, D.
    Fleury, D.
    Verier, O.
    Alenabi, F.
    Chantrel, F.
    Kessler, L.
    [J]. DIABETOLOGIA, 2018, 61 : S510 - S511
  • [8] Insulin glargine/lixisenatide fixed ratio combination improves glycaemic variability in type 2 diabetes
    Aronson, R.
    Umpierrez, G.
    Stager, W.
    Kovatchev, B.
    [J]. DIABETOLOGIA, 2016, 59 : S383 - S383
  • [9] Insulin glargine improves glycaemic control in patients with type 2 diabetes on multiple daily insulin injections confirmed by using the CGMS
    Zick, R
    Richter, M
    Schiwietz, J
    Schweitzer, MA
    Petersen, B
    [J]. DIABETOLOGIA, 2005, 48 : A305 - A306
  • [10] Insulin glargine and its role in glycaemic management of Type 2 diabetes
    Elrishi, M. A.
    Jarvis, J.
    Khunti, K.
    Davies, M. J.
    [J]. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2008, 4 (08) : 1099 - 1110
12345